Multiple dominant gain and loss of function mutations in CACNA1A have been described in patients, resulting in a spectrum of disorders: in particular, familial hemiplegic migraine (FHM)-1, Episodic ataxia (EA)-2, spinocerebellar ataxia (SCA)-6, and epilepsy. This evidence concerns the gene CACNA1A and cerebellar ataxia.